Background
Integrase strand-transfer inhibitor (INSTI)-associated weight gain among people with HIV (PWH) is greater in women than men. We assessed sex differences in cardiometabolic markers up to 5 years following INSTI initiation.
Methods
We used data collected between 2007-2020 in INSTI-naïve PWH on antiretroviral therapy (ART) for ≥2 years with viral suppression (<200 c/mL) and persons without HIV (PWOH) enrolled in the MACS/WIHS Combined Cohort Study. We compared PWH who switched/added an INSTI to those who stayed on non-INSTI ART and to PWOH. Follow-up time was years since switch visit or comparable visit in controls. Outcomes included changes in systolic and diastolic blood pressure (SBP, DBP) and fasting lipids (total cholesterol, TC, high density lipoprotein, HDL, low density lipoprotein, LDL, and triglycerides, TG). Linear regression mixed effect models assessed the effects of natal sex, study group, and time on outcomes, adjusted for time-varying age, race/ethnicity, socioeconomic status, smoking, alcohol, hypertension or cholesterol medications, and body mass index.
Results
3464 participants contributed 3.2 (±1.5) years of data, including 1938 women (411 INSTI, 709 Non-INSTI, 818 PWOH) and 1526 men (223 INSTI, 412 Non-INSTI, 891 PWOH). Pre-switch, women were younger (47 vs 55 years), more likely to be non-Hispanic Black (65 vs 23%) and had higher BMI (32 vs 27 kg/m2), compared to men. Among women, the INSTI group had greater SBP increase versus non-INSTI and PWOH up to 3 years post-switch: +6.7 mm Hg (95% CI +4.7, +8.7) vs +3.0 (+1.3, +4.8) and +3.0 (+1.6, +4.4), and greater DBP increase up to 2 years post-switch: +1.9 mm Hg (+0.9, +3.0) vs -0.4 (-1.2, +0.5) and +0.5 (-0.5, +1.0), respectively, Figure 1A. Women on INSTIs had greater decline in HDL within 1 year of switch versus non-INSTI and PWOH: -2.4 mg/dL (-4.6, -0.1) vs -0.7 (-1.0, 2.4) and +1.6 (0.1, 3.1), respectively, Figure 1B. Sex and study group modified change over time in HDL (sex*years*study group, p=0.007) but not BP. BMI was significant in BP and HDL models, p<0.001. There were no sex differences in TC, TG, or LDL change by group.
Conclusions
INSTI initiation (vs non-initiation) was associated with greater increases in BP and decreases in HDL for women but not for men, possibly consequent to greater INSTI-associated weight gain in women. Research is needed to understand the implications of INSTI-induced changes on cardiovascular outcomes in PWH.